PRKAA1 and hepatocellular carcinoma: AMPKα1 silence, using targeted-shRNAs or CRISPR-Cas9 genome editing method, not only abolished JLGTE-induced AMPK activation, but also largely attenuated following HCC cell death and apoptosis.